Showing results (241-250 of 541) with videos related to

Sort By:
Pageof 55
Liver Cancer|March 27, 2025
M2BPGi Correlated with Immunological Biomarkers and Further Stratified Recurrence Risk in Patients with Hepatocellular CarcinomaI-Cheng Lee, Hao-Jan Lei, Lei-Chi Wang, et al.
Liver Cancer|June 16, 2023
Phase 2 Study of the PD-1 Inhibitor Serplulimab plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular CarcinomaZhenggang Ren, Guoliang Shao, Jie Shen, et al.
Liver Cancer|April 3, 2026
Physical Activity Improves Overall Survival in Patients with Hepatocellular CarcinomaByeong Geun Song, Myeongcheol Lee, Juhee Cho, et al.
Liver Cancer|April 2, 2026
Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter StudyNan Jiang, Wen Zhang, Zhenwei Peng, et al.
Liver Cancer|October 30, 2023
Guidelines for the Diagnosis and Treatment of Primary Liver Cancer (2022 Edition)Jian Zhou, Huichuan Sun, Zheng Wang, et al.
Liver Cancer|April 30, 2026
Integrated Multi-Omics Profiling Identifies an Immunotherapy Vulnerable and Prognostic Associated Subtype in CholangiocarcinomaLu Chen, Yuchao He, Hong Su, et al.
Liver Cancer|June 11, 2026
Trajectory Modelling of Prognostic Biomarkers Linked to Liver Cancer Risk: A Systematic ReviewBashayr Aldawsari, Laura J Bonnett, Maria Sudell, et al.
Liver Cancer|June 25, 2026
Modality-Specific and Multilevel Barriers to Curative Treatment for Early-Stage Hepatocellular CarcinomaAshwini Arvind, Lisa Quirk, Sneha Deodhar, et al.
Liver Cancer|December 14, 2017
Prospective Comparison of Gd-EOB-DTPA-Enhanced MRI with Dynamic CT for Detecting Recurrence of HCC after Radiofrequency AblationYasuharu Imai, Kazuhiro Katayama, Masatoshi Hori, et al.
Liver Cancer|June 24, 2026
Nivolumab plus Ipilimumab versus Lenvatinib or Sorafenib as First-Line Treatment for Unresectable Hepatocellular Carcinoma: CheckMate 9DW Japanese Subgroup AnalysisMasatoshi Kudo, Atsushi Hiraoka, Kazushi Numata, et al.
Pageof 55